|
"..Retained advisor late December and CEO and layoffs within a month .. That is not too much due deligiebcr time UNLESS the offer on table is so much superior that trumps other potential options per Ladenburg advice ...
I think Ladenburg screamed to them saying take the offer ..this is going to be your best offer .. So they did the 2nd layoff and waiting to see if s better offer comes before end of April which is the time they gave for a second better offer .. If not, they will go with that..." (zoomlik mal wieder \o/ )
Und der gleiche Finanzdienstleister Ladenburg Thalmann & Co. war bei der letzten Kapitalspritze federführend:
04/15/15 -- Biodel Inc. (NASDAQ: BIOD) today announced that it has priced a public offering of 32,608,696 shares of its common stock at a price of $0.92 per share.
William Blair and Ladenburg Thalmann are acting as joint book-running managers for the offering.
Und wie schrieb KohleKies so treffend am 4.4.:
Kursziel von Ladenburg Thalmann ist von 4 auf 3,50 Dollar gesenkt.
Und diese unterstützen jetzt beim Merger!
KK
In diesem Sinne CHEERS
Thats it
...und eben nicht nur das Getrommel eines Börsenblättchens.
|
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 15 | 8.845 | Albireo neuer big player im Pharma-Milliardenmarkt | RoStock | Glatzenkogel | 23.12.23 11:22 | |
| 14 | 5.574 | Biodel - Marlboro für das Depot? | Temesta | Temesta | 09.01.23 18:25 | |
| 15 | 7.608 | ALBO Polarstern Vorraus! Für Longies und Fakten! | 1SOJ | Glatzenkogel | 09.06.22 11:14 | |
| 2 | 72 | am 30.10.2010 entscheidet hier die FDA | Lapismuc | derbestezocker | 25.04.21 01:31 | |
| 3 | 110 | Albireo Pharma DL -,01 | newbie_evo | Uhrzeit | 25.04.21 00:48 |